Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genmab A/S
Operating Expenses Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Operating Expenses
-kr12.4B
CAGR 3-Years
-43%
CAGR 5-Years
-42%
CAGR 10-Years
-35%
Zealand Pharma A/S
CSE:ZEAL
Operating Expenses
-kr1.1B
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
Ascendis Pharma A/S
NASDAQ:ASND
Operating Expenses
-€625.2m
CAGR 3-Years
-14%
CAGR 5-Years
-25%
CAGR 10-Years
-42%
B
Bavarian Nordic A/S
CSE:BAVA
Operating Expenses
-kr2.7B
CAGR 3-Years
-41%
CAGR 5-Years
-36%
CAGR 10-Years
-16%
F
Fluoguide AS
STO:FLUO
Operating Expenses
-kr43.9m
CAGR 3-Years
-26%
CAGR 5-Years
-285%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Operating Expenses
-kr82m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-10%

See Also

What is Genmab A/S's Operating Expenses?
Operating Expenses
-12.4B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Operating Expenses amounts to -12.4B DKK.

What is Genmab A/S's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-35%

Over the last year, the Operating Expenses growth was -26%. The average annual Operating Expenses growth rates for Genmab A/S have been -43% over the past three years , -42% over the past five years , and -35% over the past ten years .

Back to Top